Posted by Michael Wonder on 22 Jan 2018
Generic drug firms fall as U.S. threatens to sue for damages
19 January 2018 - U.S. may sue as part of criminal investigation: official.
Shares of generic-drug makers including Mylan and Teva Pharmaceutical Industries Ltd. fell after the Justice Department’s antitrust division said it might sue them for damages in a price-fixing probe.
If taxpayers were overcharged because drugmakers conspired to raise the price of drugs, the Justice Department will consider suing to seek damages, Makan Delrahim, the division’s chief, said in remarks Friday at George Mason University’s law school in Virginia.
“To the extent that taxpayers have had to pay that bill, I think the taxpayers should recover,” he said. “We will get involved on the civil side and recover damages for the U.S. government.”
